Better Buy: Exelixis, Inc. Vs. Novartis Ag

Several innovative new ways of fighting cancer are now either available or probably soon will be. That's generating excitement in the oncology community -- and among investors. Two companies that are front and center in the development of new treatments for cancer are Exelixis, Inc. (NASDAQ: EXEL) and Novartis AG (NYSE: NVS).Exelixis is an up-and-coming biotech with a stock that has more than tripled in value over the last 12 months.

Topics:  inc nasdaq   exel    novartis ag nyse   nvs).exelixis   images   exelixis   novartis   stock   investors   cancer   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News